The global 3D printed surgical models market size was valued at USD 451.4 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 14.8% from 2022 to 2030. This surge can be attributed to the growing demand for technological advancements in surgical tools and techniques, personalized healthcare, and 3D printed materials. The 3D printing industry gained a lot of attention in 2020 as a result of its ability to meet urgent manufacturing needs and get around the limitations of conventional manufacturing during the COVID-19 pandemic. The elements driving the growth of 3D printed surgical models include the quickly expanding need for personalized healthcare solutions and the numerous surgical applications of 3D printing.
Due to children’s smaller chest cavities than adults, surgical therapy for congenital heart disease in pediatric patients may be challenging. Surgeons can get more information by using additive fabrication for better spatial alignment within the heart’s cavities and high-fidelity stimulation of the procedure’s steps. The use of 3D-printed surgical models allows for the evaluation of the appropriate stent size, length, and position, which is beneficial for the patient’s actual intervention. It is anticipated that the market will profit from these 3D-printed surgical model properties.
Furthermore, the rising prevalence of almost all sorts of severe and chronic illnesses has also resulted in constant high demand for medical imaging, which fuels the demand for 3D-printed surgical models. To successfully plan the treatment of many conditions, especially orthopedic ones, effective and technologically advanced imaging technology is essential. In 2020, the COVID-19 pandemic had a negative impact on the industry as it delayed elective treatments and raised hospitals’ financial burden, which resulted in lower investments in state-of-the-art 3D printing technology.
Furthermore, the industry was significantly impacted by the disruption of the supply chain, the slowdown in the economy, and the reduction in operational activity across other connected markets. However, a survey by The Needham in March 2021 found that nearly 56% of the 255 participants indicated that they had open elective surgery in the last few months of 2020, indicating a rise in demand for surgical procedures post-COVID-19, which is expected to positively influence industry growth.
The 3D printed surgical models specialty segment is broadly categorized into cardiac surgery/interventional cardiology, gastroenterology endoscopy of esophageal, neurosurgery, orthopedic surgery, reconstructive surgery, surgical oncology, and transplant surgery. The orthopedic surgery segment dominated the global industry in 2021 and accounted for the largest share of more than 32.85% of the overall revenue. The main factors influencing the growth of orthopedic surgery in the market are the growing aging population and the increased prevalence & incidence of orthopedic ailments.
According to the WHO, worldwide, approximately 1.71 billion people suffer from musculoskeletal diseases. Low back pain is the sole top cause of disability in 160 different nations, and musculoskeletal diseases are the main cause of disability globally. Over the forecast period, the neurosurgery segment is anticipated to grow rapidly. This is attributed to the technological advancements in 3D printing methods and materials, as well as the increasing prevalence of neurological diseases, and the delicate architecture of the brain’s vasculature, which needs high degrees of precision in neurosurgery.
On the basis of technologies, the global industry has been further segmented into Stereolithography (SLA), ColorJet Printing (CJP), multijet/polyjet printing, Fused Deposition Modeling (FDM), and others. The Fused Deposition Modeling (FDM) segment dominated the industry in 2021 and accounted for the largest share of 26.70% of the overall revenue. In 3D printing labs for medicine, FDM printers are very economical. FDM technology, which is a subset of the material extrusion technology class, is perfect for doctors who are interested in pursuing a career in 3D printing because it is quick, easy to use, office-friendly, and enables low-cost prototype creation.
In addition, the American Society of Mechanical Engineers reports states that in 2020, material extrusion technology will be one of the most widely used technologies for surgical planning, prosthetics, and assistive devices. Multijet/polyjet printing, Stereolithography (SLA), ColorJet Printing (CJP), Fused Deposition Modeling (FDM), and others are all included in the technology area. The other sector primarily consists of technologies for directed energy deposition, powder bed fusion, and associated technologies. The others category is expected to grow quickly as a result of the growing popularity of HP’s multijet fusion technology, which belongs to the powder bed fusion class of technologies.
On the basis of materials, the global industry has been further segmented into metals, polymers, plastics, and other categories. The plastics material segment dominated the global industry in 2021 and accounted for the maximum share of more than 33.20% of the overall revenue. The segment is projected to expand further at the fastest growth rate maintaining its dominant position throughout the forecast period. The highest revenue share of plastics can be attributed to the availability of improved thermoplastics & biodegradable plastics, the relatively low cost of the material, reusability, and compatibility with a number of 3D printing technologies.
Plastics have been adopted in a significant, and ever-expanding, range of products due to their relatively low cost, ease of manufacture, versatility, and imperviousness to water. The polymers category is predicted to experience significant expansion over the forecast period due to the advent of desktop resin-based 3D printers and the versatility of these materials. The polymers segment is also estimated to expand at the second-fastest growth rate during the forecast period while the metals segment will account for the second-highest revenue share by 2030.
On the basis of geographies, the global industry has been further segmented into North America, Asia Pacific, Europe, Middle East & Africa, and Latin America. North America dominated the global industry in 2021 and accounted for the largest share of more than 34.55% of the overall revenue. According to predictions, the local market will expand due to the growing senior population and the high frequency of illnesses associated with a sedentary lifestyle. The most advanced healthcare infrastructure, including clinics & hospitals, and extensive use of cutting-edge medical services & products like 3D printing, will drive the region's growth.
A favorable reimbursement system and the presence of well-established competitors are also anticipated to boost the region’s industry share. Over the coming years, the industry is projected to expand significantly in the Asia Pacific. The need for 3D-printed surgical models is predicted to increase as a result of factors like rising per capita income levels, significant unmet medical requirements, technical improvements, and the economic development of emerging nations like China and India.
The presence of numerous domestic and foreign competitors reflects the intense competition in the market. In 2020, Stratasys Ltd., 3D Systems Inc., Materialise, and Formlabs was the major industry participants. The development of new products, mergers, acquisitions, partnerships, and collaborations are a few of the important strategic initiatives that industry participants have undertaken. For instance, Materialise expanded its 3D printing capabilities in the field of cardiology in 2021 by including new Left Atrium Appendage Occlusion (LAAO) procedure support technologies in the company’s Mimics Enlight cardiovascular planning software suite. In addition, in 2020, Fast Radius partnered with Axial3D to provide a new DICOM-to-print service for surgeons and hospitals across North America. Such strategic initiatives are anticipated to facilitate industry growth. Some of the prominent players in the global 3D printed surgical models market include:
3D Systems, Inc.
Lazarus 3D, LLC
3D LifePrints U.K. Ltd.
Market size value in 2022
USD 530.9 million
Revenue forecast in 2030
USD 1.60 billion
CAGR of 14.8% from 2022 to 2030
Base year for estimation
2018 - 2020
2022 - 2030
Revenue in USD million/billion and CAGR from 2022 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Specialty; technology; material; region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; Japan; India; South Korea; Australia; Brazil; Argentina; Mexico; South Africa; Saudi Arabia; UAE
Key companies profiled
Stratasys Ltd.; 3D Systems, Inc.; Lazarus 3D, LLC; Osteo3D; Axial3D; Onkos Surgical; Formlabs; Materialise NV; 3D LifePrints U.K. Ltd.; WhiteClouds, Inc.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 3D printed surgical models market report on the basis of specialty, technology, material, and region:
Specialty Outlook (Revenue, USD Million, 2018 - 2030)
Cardiac Surgery/Interventional Cardiology
Annuloplasty (mitral valve repair)
Repair Coronary Aneurysm
Replacement of Aortic Valve
Repair Congenital Heart Defects
Gastroenterology Endoscopy of Esophageal
Endoscopy of Esophageal lesion
Transsphenoidal Excision of Pituitary Gland
Remove Brain Tumor
Repair Clavicle Fracture
Repair Intervertebral Disc
Hip Replacement Revision
Repair Leg Fracture
Cleft Palate Correction
Removal of Adrenal Tumor
Removal of Liver Tumor
Endoscopic Removal of Cardiac Lesion
Thoracic Removal of Lung Tumor
Removal of Renal Tumor
Cardiac Surgery/ Interventional Cardiology
Technology Outlook (Revenue, USD Million, 2018 - 2030)
ColorJet Printing (CJP)
Fused Deposition Modeling (FDM)
Material Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
b. Some of the players operating in the 3D printed surgical models market include 3D Systems, Inc.; EnvisionTEC; Materialise N.V.; Stratasys Ltd.; and GPI Prototype.
b. Key factors that are driving the 3D printed surgical models market growth include growing demand for prototyping from the healthcare industry and intensive research and development activities.
b. The global 3D printed surgical models market size was estimated at USD 451.4 million in 2021 and is expected to reach USD 530.9 million in 2022.
b. The global 3D printed surgical models market is expected to grow at a compound annual growth rate of 14.8% from 2022 to 2030 to reach USD 1.60 billion by 2030
b. North America dominated the 3D printed surgical models market with a share of 34.8% in 2020. This is attributable to an increase in the geriatric population, high purchasing power, strong government support for quality healthcare, and supportive reimbursement policies in the U.S and Canada.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
The high demand and short supply of respirators due to the recent pandemic has resulted in the additive manufacturing intervention to produce medical equipment to tackle this situation. Many participants in the European region are volunteering to help the healthcare facilities by proposing the use of their 3D bioprinters. We are working to account for this change in our estimates. The report will account for COVID-19 as a key market contributor.